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Increased production of nitric oxide (NO) and subsequent local cytotoxicity to mucosal
epithelial cells has been proposed as a putative mechanism involved in the development
of necrotizing enterocolitis (NEC). Intestinal epithelial cells (IECs) metabolize L-arginine
to either nitric oxide (NO) by NO synthase (NOS) or to L-ornithine and urea by arginase.
L-ornithine is the first step in polyamine synthesis important for cell proliferation, while
NO production can lead to apoptosis. We hypothesized that in IECs immunostimulation
increases both NOS and arginase expression, and that arginase activity mitigates NO
production and apoptosis. Rat intestinal epithelial cells (rIEC-6) were immunostimulated
by either incubation with lipopolysaccharide (LPS) alone for 24 h or by incubation with
conditioned media (CM) for 24 h. CMwas obtained from RAW 264.7 cells (a macrophage
cell line) treated with LPS (E. coli 0127:B8; 1 µg/ml) for 4 h. The rIEC-6 stimulated
with LPS or with CM had significantly higher levels of inducible NOS (iNOS) protein,
NO production, and arginase II protein than did the control cells. Direct LPS stimulation
of rIEC-6 produced a less robust increase in iNOS expression and NO (represented
as nitrite percent of control) than did CM stimulation. Inhibition of arginase using Nω
hydroxyl-L-arginine (NOHA) further increased stimulated NO production in rIEC-6. Viable
cell numbers were significantly lower in CM stimulated cells after 24 h than in controls,
and inhibition of arginase activity with NOHA resulted in a further significant decrease in
viable cell numbers. We conclude that immunostimulated arginase expression of rIEC-6
cells tempers cytokine-induced iNOS-derived NO production and apoptosis.
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INTRODUCTION
Necrotizing enterocolitis (NEC) is the most common gastrointestinal emergency in preterm infants
and a leading cause of neonatal morbidity and mortality (Lin and Stoll, 2006; Neu and Walker,
2011). The incidence among very low birth weight (VLBW) infants has remained constant at 5–7%
for the past 30 years (Horbar et al., 2012). Mortality from NEC varies, depending on the amount
of bowel involvement and the presence of comorbidities, with reports of up to 50% mortality
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in patients requiring surgery for NEC (Lin and Stoll, 2006).
The pathogenesis of NEC remains unclear; however, it is likely
the result of a multifactorial process in a susceptible host. Of
particular interest is the role of inflammation-induced vascular
dysfunction and epithelial cytotoxicity in the development of
NEC (MacKendrick et al., 1993; Ford et al., 1997; Nowicki et al.,
2005).
Nitric oxide (NO) is the principal inhibitory neurotransmitter
in the gut, endothelial-derived NO is involved in the local
regulation of mucosal blood flow and inflammatory-derived
NO is involved in the loss of mucosal integrity (Stark
and Szurszewski, 1992; Alican and Kubes, 1996). Increased
production of NO and subsequent local cytotoxicity to mucosal
epithelial cells has been proposed as one of the putative
mechanisms in NEC development (Ford et al., 1997; Nadler et al.,
2000; Chokshi et al., 2008). NO is synthesized from L-arginine
by NO synthase (NOS), of which there are three isoforms
inducible NOS (iNOS), endothelial NOS (eNOS) and neuronal
NOS (nNOS) (Moncada, 1997). Of the three isoforms of NOS
described, iNOS is not constitutively expressed, but induced at
high levels during inflammation resulting in relatively high levels
of NO production (Di Lorenzo et al., 1995; Chokshi et al., 2008).
The role of iNOS-derived NO in the pathogenesis of NEC was
first described by Ford and colleagues who demonstrated elevated
iNOS expression in resected human NEC tissue compared to
non-NEC control tissue (Ford et al., 1997). In experimental
models of NEC, the inhibition of iNOS has been found to
attenuate inflammatory intestinal injury (Ciftci et al., 2004;
Giannone et al., 2006; Cintra et al., 2008).
L-arginine can be metabolized by arginase, of which there
are two isoforms, arginase I, and arginase II. Arginase I has
been described as the liver isoform, although it is found in
many cell types throughout the body, while arginase II has been
described as the inducible form of arginase and found in the
kidney and small intestine (Badurdeen et al., 2015). Arginase
converts L-arginine to L-ornithine, the first step in proline and
polyamine synthesis, which are necessary for cell proliferation,
collagen synthesis, and tissue regeneration. Alternatively, L-
arginine metabolized by iNOS generates relatively high amounts
of NO which can lead to cytotoxicity and apoptosis (Munder,
2009). We have previously found in endothelial cells and
in macrophages that arginase and NOS compete for their
common substrate, such that inhibiting arginase increased NO
production (Chicoine et al., 2004; Jin et al., 2015). Therefore,
we hypothesized that in intestinal epithelial cells inflammation
would increase both NOS and arginase II protein expression,
and that the inflammation-induced arginase activity acts to
mitigate iNOS-derived NO production and thereby mitigates
apoptosis. We used two different models of inflammation in
these studies to induce iNOS and arginase. The first was
direct treatment with lipopolysaccharide (LPS) to these cells
as previously described (Talavera et al., 2015) and the second
was to incubate the intestinal epithelial cells in conditioned
media (CM) obtained from macrophages treated with LPS
for 4 h. The LPS treatment gives insight into the direct
effect of LPS on intestinal epithelial cells, while the CM,
which would contain a mixture of cytokines and chemokines,
provides insight into what may occur in the intestinal mileu
during inflammation.
MATERIALS AND METHODS
Cell Culture
Rat intestinal epithelial cells, rIEC-6, were purchased from
the American Type Culture Collection (ATCC, Manassas, VA).
rIEC-6 cells (studied in passages 15–20) are well-described,
immortalized, immature, non-transformed rat small intestinal
epithelial cells (Quaroni et al., 1979). Cells were grown in
high glucose Dulbecco’s Modified Eagle’s Medium (DMEM,
Mediatech, Manassas, VA) supplemented with 10% fetal bovine
serum (FBS, Hyclone, Salt Lake City, UT), 100 U/ml penicillin,
100 µg/ml streptomycin, and 0.1 U/ml of recombinant human
insulin. Cells were maintained in 100 mm tissue culture plates
at 37◦C in a humidified atmosphere with 5% CO2 in ambient
air (21% O2). Cells were grown to a confluent monolayer prior
to experimentation on 60 mm or 6-well plates (Thermo Fisher
Scientific, Waltham, MA). Depending on the experiment, some
wells were treated with LPS (E. coli 0127:B8; Sigma Chemicals)
to a final media concentration of 100 µg/ml for 24 h. Other
wells were treated with conditioned media (CM) for 24 h. The
conditioned media was obtained by incubating a macrophage
cell line (RAW 264.7 cells; American Type Culture Collection,
Manassas, VA) with 1 µg/ml LPS (E. coli 0127:B8) for 4 h. The
media was then harvested and placed on rIEC-6 cells for the
indicated experiments as the immunostimulant.
Nitrite Assay
rIEC-6 cell media was collected in 1.5 ml tubes after treatment.
The samples were assayed in duplicate for nitrite (NO−2 ) using
a chemiluminescence nitric oxide analyzer (model 280i; Sievers
Instruments, Boulder, CO) as previously described (Nelin et al.,
2001; Chicoine et al., 2004). Briefly, 50 µl of sample were placed
in a reaction chamber containing a mixture of sodium iodide
(NaI) in glacial acetic acid to reduce NO−2 to NO. The NO gas
was carried into the NO analyzer by a constant flow of Helium
gas. The analyzer was calibrated with a NaNO2 standard curve.
Urea Assay
The samples of medium were assayed in triplicate for urea
concentration colorimetrically as previously described (Chicoine
et al., 2004). Briefly, 100 µl of sample was added to 1.5 ml of
chromogenic reagent (5mg thiosemicarbazide, 250mg diacetyl
monoxime, 37.5mg FeCl3 in 150 ml 25% (vol/vol) H2SO4,
20% (vol/vol) H3PO4). The mixtures were cooled to room
temperatures and the absorbance (530 nm) was determined and
compared with a urea standard curve.
RNA Isolation
RNA was isolated from rIEC-6 cells, as previously described
(Talavera et al., 2015). Briefly, 0.7 ml of TRIzol Reagent
(Invitrogen, Carlsbad, CA) was added to cells and incubated for
5 min at room temperature. Cells were scraped and the mixture
collected in 1.5 ml centrifuge tubes. Chloroform (0.1 ml) was
added, the tubes shaken for 15 s and incubated at 30◦C for 3 min.
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The mixture was then centrifuged at 12,000 × g for 15 min at
4◦C and the supernant collected. Isopropyl alcohol (0.25 ml) was
added, the mixture was incubated at 30◦C for 10 min and then
centrifuged at 7,500× g for 5 min at 4◦C. The supernatant is then
discarded, the pellet washed with 75% ethanol and centrifuged at
7,500 × g for 5 min at 4◦C. The supernatant is again discarded,
the pellet partially dried, dissolved in RNase-free water, and
stored at−80◦C.
Quantitative Real-time PCR
qPCR was performed as previously described (Talavera et al.,
2015). Briefly, 4µg of total RNAwas pretreated with RQ1 RNase-
free DNase (Promega) by incubating at 37◦C for 30 min in a
total volume of 10 µl. This reaction was terminated with the
addition of RQ1 DNase stop solution. The reaction was then
incubated at 65◦C for 10 min to inactivate the DNase. The post-
treated total RNA then underwent reverse transcription in a total
volume of 40 µl containing 2.5 µM dT16 (Applied Biosystems,
Foster City, CA), 20 units AMV-RT, 1 mM dNTP, 1x AMV
RT buffer (Promega), and RNase-free water. The samples were
incubated in a PCR-iCycler (Bio-Rad, Hercules, CA) at 42◦C for
60 min, 95◦C for 5 min, and stored at −20◦C. Quantitative real-
time PCR was performed with the Chromo 4 Real-time PCR
Detection System (Bio-Rad), using qPCR SYBR Green Master-
mix (Thermo Scientific). PCR reactions were performed for 40
cycles using the following parameters: 95◦C for 15 s, 55◦C for
30 s, 72◦C for 30 s. The melting curves were manually verified for
the presence of a single product. Arginase II was amplified using
the forward primer (5′ AGAGAAGGCGGACACATTGCCTAT
3′) and the reverse primer (5′ TGTCGTGAAAGGTGCCAGAGT
ACA 3′). iNOS was amplified using the forward primer (5′ TGTA
GCCGCTGTGTGTCACAGAAGT 3′) and the reverse primer (5′
AGCAAAGGCACAGAACTGAGGGTA 3′).18S was amplified
using the forward primer (5′ CCAGAGCGAAAGCATTTGCC
A 3′) and the reverse primer (5′ TCGGCATCGTTTATGGTC
GGAACT 3′). For each reaction, negative controls containing
reaction mixture and primers without cDNA were performed to
verify that primers and reaction mixtures were free of template
contamination. Relative arginase II and iNOS transcripts were
normalized to 18S expression using 11 CT method (Livak and
Schmittgen, 2001).
Protein Isolation
Protein was isolated from rIEC-6 cell lysate as previously
described (Jin et al., 2010; Talavera et al., 2015). Briefly, rIEC-6
cells were washed with ice-cold phosphate-buffered saline (PBS),
and 50–100 µl of lysis solution (0.2M NaOH, 0.2% SDS) was
added to each plate or each well of a six-well plate. Thirty
minutes before use the following protease inhibitors were added
to each ml of lysis solution: 1 µl aprotinin [10 mg/ml in double
distilled (dd) H2O], l µl leupeptin (10mg/ml in ddH2O), and 1
µl of phenylmethylsulfonyl fluoride (34.8 mg/ml methanol). The
rIEC-6 cells were scraped, collected into sterile centrifuge tubes,
and placed on ice for 30 min. The cell lysates were centrifuged at
12,000 × g for 15 min. The supernatant was stored at −80◦C.
Total protein concentration was determined by the Bradford
method (Bradford, 1976) using a commercially available assay kit
(Bio-Rad, Hercules, CA).
Western Blot
Cell lysate was assayed for protein levels of 3-nitro-tyrosine (3-
NT), proliferating nuclear antigen (PCNA), iNOS, arginase I,
arginase II, and cleaved-caspase-3 using immunoblot analyses
as previously described (Chicoine et al., 2004; Talavera et al.,
2015). Briefly, aliquots of cell lysate were diluted 1:1 using
SDS sample buffer, heated to 80◦C for 15 min, and then
separated using SDS-polyacrylamide gel electrophoresis. The
proteins were then transferred to polyvinylidene difluoride
membranes and blocked overnight in TBS with 0.1% Tween
(TBS-T) containing 5% nonfat dried milk. The membranes
were then incubated with primary antibody overnight; 3-
nitrotyrosine (3-NT) (1:750; Sigma Aldrich, St. Louis, MO),
PCNA (1:5000; Sigma Aldrich), arginase I (1:500; Santa Cruz
Biotechnology, Inc., Santa Cruz, CA), arginase II (1:500, Santa
Cruz Biotechnology), cleaved caspase-3 (1:1,000, Cell Signaling
Technology, Beverly, MA) or iNOS (1:1,000, BD BioSciences,
San Jose, CA). The following day, membranes were washed three
times with TBS-T, then incubated with horseradish peroxidase-
conjugate goat anti-rabbit IgG (1:10,000, Bio-Rad) for 1 h,
washed again three times with TBS-T. The protein bands
were visualized using enhanced chemiluminescence (ECL plus
reagent; Amersham Pharmacia Biotech, Piscataway, NJ) and
quantified using densitometry (Sigma Gel, Jandel Scientific, San
Rafael, CA). To control for protein loading, the blots were
stripped using a stripping buffer containing 62.5 mM Tris HCl
(pH 6.8), 2% SDS, and 100 mM β-mercaptoethanol, and the
blots were reprobed for β-actin (1:10,000; Abcam, Cambridge,
MA) as described above. Data are shown as the mean of the
density of the protein of interest normalized to the density of
β-actin.
Proliferation Assay
To determine cell proliferation, rIEC-6 cells were seeded
in six-well plates at a density of 1 × 105 cells/well. The
cells were incubated in regular DMEM or in CM for 24
h and viable cells counted using trypan blue exclusion.
To determine the effects of arginase inhibition on rIEC-6
proliferation following immunostimulation, cells were
incubated in CM with either vehicle or 100 µM Nω-Hydroxy-
nor-L-arginine (NOHA) added for 24 h and viable cells
counted using trypan blue exclusion. In a separate set of
proliferation experiments, using the same methodology as
above, the effect of NOS inhibition on cell proliferation was
determined by adding either vehicle or Nω-nitro-L-arginine
methyl ester (L-NAME) to CM, incubating the cells for
24 h, and then counting the viable cells using trypan blue
exclusion.
Statistical Analysis
Values are expressed as means ± SEM. The groups were
compared using a t-test when 2 groups were compared or a
one-way analysis of variance (ANOVA) or two-way ANOVA
when more than two groups were compared. For the ANOVA
a Student-Newman-Keuls post-hoc test was used to identify
significant differences. Differences were considered significant
when p< 0.05 (Prism; GraphPad Software, San Diego, CA).
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RESULTS
LPS-Induced Nitric Oxide Production in
rIEC-6 Cells
To determine the effects of LPS on nitric oxide and urea
production in enterocytes, cells were grown to∼ 80% confluence,
treated with LPS (E. coli 0127:B8) or left untreated (control)
for 24 h. The cells were harvested for RNA and analyzed by
qRT-PCR. There was increased iNOS mRNA levels (p < 0.05)
from LPS stimulated cells as compared with unstimulated IECs
(Figure 1A). Cell lysates were collected and evaluated byWestern
blot for iNOS protein levels. The LPS-treated cells showed ∼7-
fold greater iNOS protein expression than control (p < 0.001)
(Figure 1B). In a similar set of experiments, the cell media
was examined for production of nitrites as a marker of NO
production. LPS-treated cells had substantially greater (p <
0.001) NO concentration (represented as percent control) than
did control cells (Figure 1C).
To examine LPS effects on arginase, cell lysates were assayed
for arginase I and arginase II mRNA and protein levels. There was
no significant effect of LPS on arginase I mRNA or protein levels
in these rIEC-6 cells (data not shown). However, LPS-treated cells
had substantially greater levels of arginase II mRNA (Figure 1D)
and arginase II protein (Figure 1E) than did control cells. The
cell media was also assayed for urea production. The LPS-treated
rIEC-6 cells significantly greater (p < 0.001) urea concentration
(represented at percent of control) that did vehicle-treated cells
(Figure 1F).
LPS-induced Nitrite Production Is
Enhanced by Arginase Inhibition
To determine the role of arginase activity in LPS-induced NO
production in rIEC-6 cells we utilized the putative arginase
inhibitor NOHA. Cells were either not treated or treated with LPS
and the LPS-treated cells were also treated with vehicle or NOHA
(100 µM). The media was collected 24 h later and assayed for
nitrites and urea. LPS-treated cells had significantly greater urea
production than control cells and NOHA treatment attenuated
the LPS-induced increase in urea production (Figure 2). LPS-
treated cells had substantially greater NO production than did
control cells and treatment with NOHA augmented LPS-induced
NO production (Figure 2). These findings are consistent with the
concept that arginase acts to limit iNOS-derived NO production
in LPS stimulated rIEC-6 cells.
Arginase Inhibition Results in Greater
Cytotoxicity and Decreased Proliferation in
LPS-treated rIEC-6 Cells
To examine the effects of arginase inhibition on NO-mediated
cytotoxicity in LPS-treated rIEC-6 cells, we performed Western
blot analyses for 3-nitrotyrosine—(3-NT) protein expression. 3-
NT is a marker for peroxynitrite formation, which is formed
in the presence of NO and superoxide during conditions of
oxidative stress. LPS-treatment resulted in a significant increase
in 3-NT level and treatment with LPS + NOHA resulted
in greater 3-NT levels than in LPS-treated cells (Figure 3A).
Inhibtion of arginase in control cells also led to a significant
production of 3-NT but not significantly more than arginase
inhibition following LPS stimulation (p< 0.001) (Figure 3A).
We also examined protein levels of proliferating cell nuclear
antigen (PCNA), a marker of cell proliferation in each
experimental group, hypothesizing that if NO production were
greater in the LPS treated cells that PCNA levels would be
lower and that arginase inhibition would further lower PCNA
protein levels. We found a significantly lower level of PCNA
protein in LPS-treated cells than in control cells (Figure 3B).
Furthermore, when arginase was inhibited in the LPS-treated
cells the levels of PCNA were lowest (Figure 3B). These results
indicate that arginase inhibition in LPS-treated enterocytes lead
greater nitrosative damage and decreased cell proliferation.
CM Increases iNOS and Arginase II Protein
Levels
To examine the effect of another form of immunostimulation on
iNOS and arginase II protein levels rIEC-6 cells were treated with
either CM or regular media (control) for 24 h. Cell lysates were
examined for iNOS and arginase II protein levels byWestern blot
analysis. Following CM stimulation, iNOS protein levels were
substantially higher than in control cells (Figure 4A). The fold
increase in iNOS protein levels with CM relative to control were
substantially greater than the fold increase in iNOS protein levels
with LPS stimulation alone. Similarly, in cells incubated in CM
the arginase II protein levels were significantly higher than in
the control cells (Figure 4B). Interestingly, the fold change in
arginase II levels relative to control caused by CM was similar
to that seen with LPS.
Treatment with CM Increased Apoptosis in
rIEC-6 Cells
To begin to examine the effects of iNOS induction on cell
viability, the protein levels of cleaved caspase-3 were determined
in rIEC-6 cells following incubation in CM. The cleaved caspase-
3 levels were nearly 10-fold greater (p < 0.0001) in rIEC-6 cells
incubated in CM compared to control cells (Figure 5). This data
suggest that the CM-induced increase in iNOS protein levels in
rIEC-6 cells was associated with the greater apoptosis.
Inhibition of Arginase Results in Greater
NO Production and Fewer Viable Cells
To determine the effects of CM and arginase inhibition on rIEC-6
NO production, rIEC-6 cells were grown to 80% confluence and
then incubated in CM or regular media with either vehicle or 100
µM NOHA added for 24 h. Nitrite levels were measured in the
media. Similar to our findings with LPS alone, treatment with
CM resulted in a substantially greater nitrite levels than in control
cells (Figure 6A). Inhibiting arginase with NOHA in the CM-
treated cells resulted in substantially greater nitrite levels than in
the CM and vehicle treated cells (Figure 6A).
To determine the effect of CM on viable cell number, rIEC-6
cells were seeded at a density of 1 × 105 cells/well in a six-well
plate. These cells were then treated with regular media (control),
CM or CM with 100 µMNOHA for 24 h and viable cell numbers
Frontiers in Cell and Developmental Biology | www.frontiersin.org 4 March 2017 | Volume 5 | Article 15
Talavera et al. Immunostimulated Arginine Metabolism in Enterocyte
FIGURE 1 | LPS induced NO and urea production. rIEC-6 cells were treated with LPS or vehicle (control) for 24 h. (A) iNOS mRNA levels detected by qRT-PCR
normalized to 18srRNA levels (n = 6 for each group). (B) Cell lysates were harvested and iNOS protein levels determined by Western blot. The densitometry data
(n = 3 for each group) normalized to β-actin are shown relative to control. (C) Nitrites were analyzed by chemiluminescence for media harvested after a 24 h
incubation with vehicle (control) or LPS (n = 9 for each group). Nitrite levels were measured in media and represented as a percent of control. (D) Cell lysates were
examined for arginase II mRNA levels using qPCR normalized to 18s rRNA (n = 6 for each group). Densitometry results are shown as fold change from control (where
control levels = 1). (E). Cell lysates were examined for arginase II protein levels by Western blot (n = 4 for each group). The densitometry data normalized to β-actin
are shown relative to control. (F). Urea production was determined by colorimetric assay after harvesting medium from cells treated with vehicle (control) or LPS (n = 6
for each group). Urea levels were measured in media and are represented as a percent of control urea values. *LPS different from control, p < 0.05, **LPS different
from control, p < 0.001.
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FIGURE 2 | LPS-induced NO production was augmented when urea
production was inhibited. rIEC-6 cells were incubated for 24 h in media
containing LPS and either vehicle or 100 µM Nω-Hydroxy-nor-L-arginine
acetate (NOHA). Urea (black bars) was measured using a colorimetric assay
and the results are presented as percent of control (i.e., no LPS) urea values.
Nitrites (gray bars) were measured in the media and are presented as a
percent of control nitrite values. **LPS different from control; **LPS+NOHA
different from control + NOHA, p < 0.001; multiple t-test and 2-way ANOVA.
determined using trypan blue exclusion. Treatment of rIEC-6
cells with CM resulted in significantly fewer viable cells than
in control rIEC-6 cells (Figure 6B). Addition of NOHA to the
CM resulted in significantly fewer viable cells than in the cells
incubated in CM and vehicle (Figure 6B). These findings support
a role for arginase in attenuating iNOS generated NO production
to preserve rIEC-6 cell viability following inflammatory stimuli.
Inhibiting Arginase Augments Apoptosis,
While Inhibiting NOS Attenuates Apoptosis
To determine the role of arginase inhibition on enterocyte
apoptosis, rIEC-6 cells were grown to ∼80% confluence then
stimulated with either CM or CM + NOHA (100 µM) for 24 h.
Cell lysate was collected and protein harvested. Cleaved caspase-
3 protein levels were determined by Western blot analyses.
We found significantly greater cleaved caspase- 3 protein levels
in the rIEC-6 cells treated with CM + NOHA than in cell
treated with CM alone (Figure 7A). To determine the role
of immunostimulated NO production on enterocyte apoptosis,
rIEC-6 were incubated in either CM or CM + L-NAME (100
µM) for 24 h. Cell lysates was collected and protein harvested.
Cleaved-caspase-3 protein levels were determined by Western
blot analyses. The CM + L-NAME treated cells had significantly
lower (p < 0.001) cleaved caspase-3 protein levels than did cells
incubated in CM alone (Figure 7B). These results suggest that
during intestinal inflammatory conditions arginase expression in
enterocytes may temper iNOS-mediated apoptosis.
FIGURE 3 | Arginase inhibition resulted in increased 3-nitrotyrosine and
decreased proliferation in LPS-treated rIEC-6 cells. rIEC-6 cells were
treated with LPS or untreated (control), and either with the arginase inhibitor
(NOHA) or its vehicle for 24 h. Cell lysate was examined for 3-NT, PCNA or
β-actin by Western blot. (A). Densitometry data for 3-NT normalized to β-actin
and presented as fold change from control (n = 6 for each group); **LPS+
NOHA-treated different from control + NOHA; LPS + NOHA different from LPS
alone; LPS different from control; Control + NOHA different from control, p <
0.001. (B). Densitometry data for PCNA normalized to β-actin and presented
as fold change from control (n = 9 for each group); #LPS different from
LPS+NOHA control, p < 0.05. *LPS+NOHA different from control, p < 0.001.
DISCUSSION
The major findings of this study in rIEC-6 were that:
(1) immunostimulation increased iNOS and arginase II
protein levels, as well as NO and urea production; (2)
inhibiting arginase resulted in greater immunostimulated
NO production; (3) immunostimulation increased apoptosis;
(4) inhibition of arginase resulted in further decreased
viable cell number and increased apoptosis following
immunostimulation; and (5) inhibition of NOS production
attenuated apoptosis following immunostimulation. These
findings support our hypothesis that immunostimulation
of intestinal epithelial cells increased both iNOS and
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FIGURE 4 | Conditioned media up-regulates iNOS and arginase II
protein levels. rIEC-6 cells were exposed to conditioned media (CM) for 24 h.
CM media (DMEM with FBS) was collected from RAW 264.7 cells stimulated
with 1 µg/ml LPS for 4 h. (A) Cell lysates (n = 6 for each group) were
examined for protein levels of iNOS by western blotting. (B) The densitometry
data normalized to β-actin are shown relative to control. (C) Cell lysates (n = 6
for each group) were examined for protein levels of arginase II by western
blotting. (D) The densitometry data normalized to β-actin are shown relative to
control. *CM different from control, p < 0.005.
arginase II protein expression and that arginase activity
mitigated iNOS-derived NO production and subsequent
apoptosis.
In this study we used two methods of experimental
immunostimulation of rIEC-6 cells: direct LPS stimulation
and incubation with conditioned media from LPS-stimulated
FIGURE 5 | Condtioned media increased apoptosis in rIEC-6 cells. Cells
were exposed to conditioned media (CM) for 24 h. CM media (DMEM and
FBS) was collected from RAW 264.7 cells stimulated with 1 µg/ml LPS for 4 h.
Cell lysates were examined for levels of cleaved caspase-3 by western
blotting. Typical western blots for cleaved caspase-3 and β-actin. The bar
graph shows the densitometry data for cleaved caspase 3 normalized to
β-actin (n = 6 for each group) are shown relative to control (i.e., control = 1).
*CM different from control, P < 0.005.
macrophage cell line. The conditioned media would be expected
to contain biologically relevant levels of a wide-variety of
chemokines and cytokines. Intestinal epithelial cells (IECs) are
in nearly constant contact with bacteria and bacterial products
(LPS) and during inflammatory states there can be significant
influx of inflammatory cells including macrophages (De Plaen,
2013). IEC’s express cytokine receptors and secrete cytokines in
response to inflammatory stimuli (Jung et al., 1995; Reinecker
and Podolsky, 1995). We have previously shown that rIEC-
6 cells express both TNF-α and COX-2 following direct LPS
stimulation (Talavera et al., 2015). In this study, we found that
both direct LPS and cytokine-induced (CM) immunostimulation
resulted in greater expression of both arginase II and iNOS
in rIEC-6 cells. Our data supports the notion that enterocyte-
derived iNOS is up-regulated during inflammatory states and
is responsible for high levels of NO production (Grishin et al.,
2016).
These high levels of NO production can exert detrimental
effects on the gut barrier leading to increased permeability,
increased bacterial translocation (Hackam, 2011), impaired
mitochrondrial function (Erusalimsky and Moncada, 2007), and
impaired epithelial restitution following injury (Cetin et al.,
2007). We found that enterocyte-derived iNOS expression
in response to both LPS and conditioned media conditions
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FIGURE 6 | Conditioned media results in more NO production and
fewer viable cells and inhibition of arginase augments this response.
rIEC-6 cells were incubated in either regular media (control) or conditioned
media (CM), and with either vehicle or 100 µM NOHA added for 24 h. (A).
Media was harvested for determination of NO production by assaying nitrites
using chemiluminescence. Conditioned media resulted in a substantially
greater NO production in vehicle treated cells (black bars) than did regular
media (control). Inhibiting arginase with NOHA (gray bars) augmented the
CM-induced production of NO. *CM different from control, p < 0.001. # NOHA
different from vehicle, p < 0.005. (B). Equal numbers of rIEC-6 cells were
seeded in each well of 6 well plates and treated as above. After 24 h viable cell
numbers were determined using trypan blue exclusion. *CM different from
control, p < 0.05. #CM + NOHA different from CM, p < 0.05.
parallel elevated NO levels (Figures 1, 3) and cleaved caspase-3
(Figure 4) expression. Cytoplasmic NO readily and very
rapidly reacts with superoxide to form peroxynitrite, which
is cytotoxic to enterocytes by the formation of nitrotyrosine
residues alterating protein enzymatic activity (Schopfer et al.,
2003; Grishin et al., 2016). We have shown that direct LPS
stimulation following arginase inhibition significantly increased
3-nitrotyrosine levels and decreased PCNA levels in rIEC-
6 cells. We also demonstrated that in the presence of a
small molecule arginase inhibitor, NOHA, iNOS-dependent NO
production was increased in rIEC-6 cells, and that this increase
in NO production resulted in fewer viable cells. Thus, our
FIGURE 7 | Inhibition of arginase augments, while inhibition of iNOS
attenuates, enterocyte apoptosis. rIEC-6 cells were grown ∼80%
confluence then incubated in either conditioned media (CM) alone or CM and
the arginase inhibitor, NOHA (A), or CM alone or CM + the iNOS inhibitor,
L-NAME (B), for 24 h. Cell lysates were collected and protein harvested to
determine cleaved caspase-3 and β-actin protein levels. (A). Representative
Western blots for cleaved caspase-3 and β-actin in CM and CM +
NOHA-treated cells (n = 9 each group). The bar graph is the densitometry
data for cleaved caspase-3 normalized to β-actin and shown relative to CM
alone. *p < 0.05 CM + NOHA different than CM alone. (B). Representative
Western blots for cleaved caspase-3 and β-actin in CM and CM +
L-NAME-treated cells (n = 9 for each group). The bar graph is the
densitometry data of cleaved caspase-3 normalized to β-actin as shown
relative to CM alone. *p < 0.001 CM + L-NAME different than CM alone.
data supports a central role of iNOS in enterocyte apoptosis,
which would be expected to lead to decreased barrier function
in vivo.
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The opposing biological effects of iNOS and arginase in
response to inflammation are mainly due to the cytopathic effects
of NO compared to the regenerative, proliferative effects of
arginase on the cellular environment (Hibbs, 1991; Chokshi et al.,
2008). Others have shown how specific inflammatory ligands
will determine a predominant iNOS or arginase expression. For
example, in murine macrophages Th2 cytokines (IL-4 and IL-10)
are potent inducers of arginase, whereas Th1 cytokine -INF-γ
is a potent inducer of iNOS (Modolell et al., 1995). Similarly,
in mouse peritoneal exudate cells, the growth factor, TGF-β,
attenuated INF-γ-induced increased iNOS activity resulting
in increased arginase activity (Shearer et al., 1997). In this
study, we demonstrated that direct LPS stimulation of rIEC-
6 cells resulted in arginase II induction and increased urea
production. Concurrently, direct LPS stimulation also induced
iNOS activity and increased NO production. It is unclear if
iNOS and arginase II induction following either LPS or CM
stimulation results from similar signaling cascades or if different
signaling cascades are involved. In RAW cells, we recently
reported that extracellular-signal regulated kinase (ERK) was
involved in arginase II induction but that p38 was necessary
for iNOS induction following LPS stimulation (Jin et al., 2015).
Further studies will be needed in enterocytes to determine if
similar cellular mechanisms are involved in immune-mediated
iNOS and arginase II induction.
The dynamic interplay between iNOS and arginase activities
has been reported in other cell types including vascular
endothelium, macrophages and gastrointestinal epithelium
(Eckmann et al., 2000; Berkowitz et al., 2003; Chicoine et al.,
2004; Miki et al., 2009; Jin et al., 2015). In this report we studied
the relative roles of immunostimulated iNOS and arginase II in
intestinal epithelial cell NO production. We demonstrated that
treatment with conditioned media (CM) induced a significantly
greater iNOS expression compared to arginase II in rIEC-
6 cells. We also demonstrated that cytokine-induced nitrite
production was increased by arginase inhibition in rIEC-6
cells. These findings are consistent with a previous study in
LPS/TNF-α-stimulated endothelial cells, wherein inhibition of
arginase resulted in an increase in NO production (Chicoine
et al., 2004). Our lab has also demonstrated that when LPS-
induced arginase II expression in RAW 264.7 cells was prevented
using a siRNA against arginase II, iNOS-derived NO production
was substantial enhanced (Jin et al., 2015). These findings suggest
that following immunostimulation in various cell types including
enterocytes, arginase and iNOS compete for their common
substrate, L-arginine, such that decreasing arginase activity leads
to an increase in NO production. Thus, arginase activity is
involved in cellular regulation of inflammatory NO production
in intestinal epithelial cells.
Enhanced apoptosis in intestinal epithelial cells is a hallmark
of intestinal barrier dysfunction, which is thought to be an
important pathogenic feature for NEC in preterm infants
(De Plaen, 2013). The increased enterocyte apoptosis observed
in NEC has been shown to correlate with an increase in
iNOS activity and 3-NT staining (Nadler et al., 2000). In this
study, we demonstrated that inhibition of iNOS-induced NO
production attenuated apoptosis in rIEC-6 cells, as evidenced by
substantially lower levels of cleaved caspase-3 in cells treated with
a NOS inhibitor, L-NAME.While augmenting iNOS-derived NO
production by arginase inhibition resulted in significantly greater
levels of cleaved caspase-3. These findings highlight the cytotoxic
effects of iNOS-derived NO in rIEC cells and the role of arginase
activation in attenuating inflammation-induced NO-mediated
apoptosis.
In conclusion, we demonstrated that inflammation-induced
NO production in rIEC-6 is iNOS mediated and leads to
cytotoxicity and decreased viable cell numbers. We found that
inflammation-induced arginase activity in enterocytes mitigates
the effects of iNOS-derived NO production by attenuating
NO production and the resultant apoptosis. These findings
suggest that inhibition of iNOS and/or augmentation arginase
II activities in enterocytes may be viable therapeutic strategies
to prevent epithelial cell apoptosis and loss of barrier function.
It is important to remember though that some level of NO is
needed to maintain mucosal homeostasis, vascular tone, and
oxidative stress, while relatively high levels of NO, as seen
with iNOS induction, lead to apoptosis. Our findings suggest a
potential therapeutic target would be augmented arginase activity
in inflamed intestinal epithelial cells as a means to prevent
disease progression and facilitate early proliferation and repair.
We further speculate that neonates with lower degrees of arginase
induction, perhaps due to genetic mutations in their arginase II
genes, may be more prone to develop NEC.
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